• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

Mechanisms and Interventions of SIX1 in Esophageal Squamous Cell Carcinoma

Corresponding author: Yang Wenrong, 820099200@qq.com
DOI: 10.12201/bmr.202611.00032
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Objective To evaluate the reversibility of esophageal squamous cell carcinoma cell phenotypes following SIX1 downregulation and the extent of functional restoration by AKT rescue. Methods Sixty paired tumor and adjacent tissue samples and six independent culture batches for each of the KYSE150 and KYSE30 cell lines were analyzed. Six groups comprised a negative control, two SIX1 knockdown groups, SIX1 re-expression, AKT rescue, and an AKT activation control. Tissue expression, cell growth, invasion, apoptosis, and associated protein changes were evaluated. Results: Tumor SIX1 transcript expression was 2.63-fold that of adjacent tissue, with a mean H-score increase of 111.83 points. Knockdown 1 reduced the 72-hour growth index to 0.565 and 0.658 of control values and increased apoptosis by 9.43 and 10.01 percentage points in KYSE150 and KYSE30, respectively. Invasion, pAKT/AKT and BCL2 decreased, whereas BIM increased. SIX1 re-expression and AKT rescue improved growth and apoptosis, but apoptosis after AKT rescue remained above control levels, and statistical evidence for invasion rescue was insufficient. Conclusion SIX1 downregulation is associated with attenuated malignant phenotypes, with AKT-associated signaling contributing to partial functional restoration. Rescue varies across endpoints, and statistical robustness is limited by the small sample size. These findings do not establish a complete direct regulatory mechanism.

    Key words: Esophageal squamous cell carcinoma; SIX1; AKT; Apoptosis; Functional rescue

    Submit time: 17 November 2026

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • Jing ZHAO, Junxia HUANG, Xiuhua TANG, Hong WANG. The role of HOXA11-AS/miR-149-3p pathway in the malignant phenotype of lung squamous cell carcinoma. 2022. doi: 10.12201/bmr.202204.00005

    JIA Mengmeng, DING Dandan, ZHOU Yingfa. Research on the subclassification of type B2 vessels in determining the depth of invasion of superficial esophageal carcinoma. 2026. doi: 10.12201/bmr.202601.00002

    Duan Wei, Tang Xi. . 2026. doi: 10.12201/bmr.202610.00035

    黎强, CHEN ShiJuan, YANG Yanan, LIU Liren. Effects of Qingre Antai Gel on ANXA1/FPR2 Axis and Cell Apoptosis in Gingival Tissue of Rats with Pregnancy Gingivitis. 2026. doi: 10.12201/bmr.202610.00028

    HU Wei,. Clinical Efficacy of Penpulimab Combined Chemotherapy in Non-Squamous NSCLC. 2025. doi: 10.12201/bmr.202508.00045

    DAI Xin-zhen, LIAO Yan-ting, LUO Xiao-wan, FU Li-hua. LUO Yan-yan1, DAI Xin-zhen2, LIAO Yan-ting1, LUO Xiao-wan2, FU Li-hua1. 2024. doi: 10.12201/bmr.202410.00056

    Duan Lingzhi, Yu Yingping, Li Huimin, Wang Xiang, Zhang Aihua. Mechanism of HIF-1 Signaling Pathway in Obstructive Sleep Apnea and Current Research Status of Traditional Chinese Medicine Interventions. 2025. doi: 10.12201/bmr.202512.00021

    Zhao Xiansheng, Hu Airong, Gao Guosheng. Research Progress of Splicing Factor SART1 in Viral Infection and Immune Regulation. 2026. doi: 10.12201/bmr.202605.00065

    WANG Lei. The Role of Gastrointestinal Tumor Markers and Inflammatory Indicators in the Diagnosis and Treatment of Esophageal Cancer. 2025. doi: 10.12201/bmr.202510.00034

    YANG Renyi, TONG Tianhao, ZENG Puhua. Exploring the differentiation and treatment principles of esophageal cancer based on the. 2026. doi: 10.12201/bmr.202610.00051

  • ID Submit time Number Download
    1 2026-10-22

    10.12201/bmr.202611.00032V1

    Download
  • Public  Anonymous  To author only

Get Citation

Yang Wenrong. Mechanisms and Interventions of SIX1 in Esophageal Squamous Cell Carcinoma. 2026. biomedRxiv.202611.00032

Article Metrics

  • Read: 48
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误